Guangxi's Leading Synthetic Biology Firm Announces Strategic AI Collaboration to Accelerate Cell Factory Development

May 30, 2025 17:55 CST Updated 17:55

BioGeometry

Large Molecule Drug Developer

On May 29, synthetic biology companyHanhe BioAndBioGeometryHeld"AI-Driven Synthetic Biology Technology Accelerates the Construction of Cell Factories"”Strategic Cooperation Signing.

It is reported that the two parties will use machine learning to analyze massive genomic and metabolomic data to predict the optimal gene editing sites or metabolic pathway modification solutions.

Deep collaboration unfolds around core technologies such as generative AI-driven enzyme design, enzyme mining, strain modification, metabolic pathway optimization, and cell factory design, promoting the deep integration and application of "artificial intelligence + synthetic biology."

Shorten the traditional "trial-and-error" strain R&D cycle (months to years) to just a few weeks.By combining AI technology with synthetic biology, the construction of Hanhe Bio's efficient cell factories is accelerated.

Synthetic Biology Enterprises Move Towards Strong Alliances

BioGeometry was founded in 2013,It is a company with microbial engineering, enzyme engineering, and synthetic biology as its core technologies., andIt has the only "Key Laboratory of Microbial Fertilizers" of the Ministry of Agriculture and Rural Affairs in China.

Nowadays, the company has grown into the largest private synthetic biologics production enterprise in Guangxi.Total operating revenue in 2024: 813 million yuan, referred to asGuangxi Synthetic Biology "Leader".

The companyR&D centers have been established in Nanning and Shenzhen, respectively, with in-depth cooperation carried out with scientific research institutions such as the Tianjin Institute of Industrial Biotechnology of the Chinese Academy of Sciences and Jiangnan University.The future will deepen gene editing and metabolic engineering.And other technologies, developmentNovel Biostimulants and Green Materials, promoting the upgrading of agriculture and food industry.

AndBioGeometry was founded in 2022, isA generative AI-driven protein design and R&D platform company,Focused on building a generative AI protein design platform to empower the entire biomanufacturing field.。

Based on its self-developed generative AI large model, BioGeometry has developedGeoBiologicsOne-stop protein design platform, currently has reached multiple cooperations.

Including withAlibaba CloudJointly Build AI-Powered Intelligent Solutions for Biomanufacturing, withSanyou Biologics, Baijun BiologicsCollaboratively build antibody design generative AI large models, and withXiangyao Biotech, Yinka BiotechPromote the co-development of protein and antibody drug products.

In 2024, the company andAgricultural GiantDabeinongCooperationJointly Build the Zhongguan Village Bio-Manufacturing Innovation Center, covering areas such as biosynthesis, proteomics, AI protein design, healthcare, artificial intelligence+, and more.

Recommended Reading